FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896442353> ?p ?o ?g. }

• W2896442353 endingPage "201" @default.
• W2896442353 startingPage "193" @default.
• W2896442353 abstract "Visceral leishmaniasis and HIV coinfection: current perspectives José Angelo Lauletta Lindoso,1–3 Carlos Henrique Valente Moreira,1,4 Mirella Alves Cunha,5 Igor Thiago Queiroz6,7 1Instituto de Infectologia Emilio Ribas, São Paulo, Brazil; 2Nucleo de Medicina Tropical, Universidade de Brasília, Brasília, Brazil; 3Laboratorio de Soroepidemiologia, Institutode Medicina Tropical, Universidade de São Paulo, São Paulo, Brazil; 4Laboratorio de Parasitologia, Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo, Brazil; 5Departamento de Infectologia, Universidade Federal do Rio Grande do Norte, Natal, Brazil; 6Universidade Potiguar (UnP), Laureate International Universities, Natal, Brazil; 7Hospital Giselda Trigueiro (SESAP/RN), Natal, Brazil Abstract: Visceral leishmaniasis (VL) is caused by Leishmania donovani and Leishmania infantum. The burden of VL is concentrated in tropical and subtropical areas; however, HIV infection has spread VL over a hyperendemic area. Several outcomes are observed as a result of VL–HIV coinfection. Impacts are observed in immunopathogenesis, clinical manifestation, diagnosis, and therapeutic response. Concerning clinical manifestation, typical and unusual manifestation has been observed during active VL in HIV-infected patient, as well as alteration in immunoresponse, inducing greater immunosuppression by low CD4 T-lymphocyte count or even by induction of immunoactivation, with cell senescence. Serological diagnosis of VL in the HIV-infected is poor, due to low humoral response, characterized by antibody production, so parasitological methods are more recommended. Another important and even more challenging point is the definition of the best therapeutic regimen for VL in HIV-coinfected patients, because in this population there is greater failure and consequently higher mortality. The challenge of better understanding immunopathogenesis in order to obtain more effective therapies is one of the crucial points to be developed. The combination of drugs and the use of secondary prophylaxis associated with highly active antiretroviral therapy may be the best tool for treatment of HIV coinfection. Some derivatives from natural sources have action against Leishmania; however, studies have been limited to in vitro evaluation, without clinical trials. Keywords: visceral leishmaniasis, HIV infection, AIDS, diagnosis, therapeutic response" @default.
• W2896442353 created "2018-10-26" @default.
• W2896442353 creator A5019350602 @default.
• W2896442353 creator A5057422785 @default.
• W2896442353 creator A5068890126 @default.
• W2896442353 creator A5075088781 @default.
• W2896442353 date "2018-10-01" @default.
• W2896442353 modified "2023-10-18" @default.
• W2896442353 title "Visceral leishmaniasis and HIV coinfection: current perspectives" @default.
• W2896442353 cites W1491047621 @default.
• W2896442353 cites W1747785120 @default.
• W2896442353 cites W1870737176 @default.
• W2896442353 cites W1904448194 @default.
• W2896442353 cites W1965394496 @default.
• W2896442353 cites W1968238739 @default.
• W2896442353 cites W1983173704 @default.
• W2896442353 cites W1983812090 @default.
• W2896442353 cites W1989306682 @default.
• W2896442353 cites W1992045706 @default.
• W2896442353 cites W1997454962 @default.
• W2896442353 cites W2002252754 @default.
• W2896442353 cites W2003104596 @default.
• W2896442353 cites W2009546537 @default.
• W2896442353 cites W2023814018 @default.
• W2896442353 cites W2030364077 @default.
• W2896442353 cites W2031187765 @default.
• W2896442353 cites W2032761636 @default.
• W2896442353 cites W2037082550 @default.
• W2896442353 cites W2038565126 @default.
• W2896442353 cites W2043254099 @default.
• W2896442353 cites W2047265839 @default.
• W2896442353 cites W2057048509 @default.
• W2896442353 cites W2069077979 @default.
• W2896442353 cites W2070674610 @default.
• W2896442353 cites W2070844208 @default.
• W2896442353 cites W2074505948 @default.
• W2896442353 cites W2075924237 @default.
• W2896442353 cites W2076026695 @default.
• W2896442353 cites W2080942608 @default.
• W2896442353 cites W2081440055 @default.
• W2896442353 cites W2086258935 @default.
• W2896442353 cites W2091117213 @default.
• W2896442353 cites W2094729712 @default.
• W2896442353 cites W2100665783 @default.
• W2896442353 cites W2101055145 @default.
• W2896442353 cites W2103096231 @default.
• W2896442353 cites W2107022019 @default.
• W2896442353 cites W2113879666 @default.
• W2896442353 cites W2114155751 @default.
• W2896442353 cites W2117860338 @default.
• W2896442353 cites W2118412580 @default.
• W2896442353 cites W2121285568 @default.
• W2896442353 cites W2126420606 @default.
• W2896442353 cites W2131241291 @default.
• W2896442353 cites W2134253010 @default.
• W2896442353 cites W2136269153 @default.
• W2896442353 cites W2139588481 @default.
• W2896442353 cites W2142409861 @default.
• W2896442353 cites W2146431258 @default.
• W2896442353 cites W2154111760 @default.
• W2896442353 cites W2156802725 @default.
• W2896442353 cites W2168223850 @default.
• W2896442353 cites W2171319003 @default.
• W2896442353 cites W2171647918 @default.
• W2896442353 cites W2188200969 @default.
• W2896442353 cites W2262786583 @default.
• W2896442353 cites W2298597695 @default.
• W2896442353 cites W2303463723 @default.
• W2896442353 cites W2415101278 @default.
• W2896442353 cites W2418321755 @default.
• W2896442353 cites W2528151722 @default.
• W2896442353 cites W2559440574 @default.
• W2896442353 cites W2609004982 @default.
• W2896442353 cites W2747741306 @default.
• W2896442353 cites W2757750938 @default.
• W2896442353 cites W2765873700 @default.
• W2896442353 cites W2768905830 @default.
• W2896442353 cites W2789272566 @default.
• W2896442353 cites W4240133843 @default.
• W2896442353 cites W904705693 @default.
• W2896442353 doi "https://doi.org/10.2147/hiv.s143929" @default.
• W2896442353 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6197215" @default.
• W2896442353 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30410407" @default.
• W2896442353 hasPublicationYear "2018" @default.
• W2896442353 type Work @default.
• W2896442353 sameAs 2896442353 @default.
• W2896442353 citedByCount "50" @default.
• W2896442353 countsByYear W28964423532019 @default.
• W2896442353 countsByYear W28964423532020 @default.
• W2896442353 countsByYear W28964423532021 @default.
• W2896442353 countsByYear W28964423532022 @default.
• W2896442353 countsByYear W28964423532023 @default.
• W2896442353 crossrefType "journal-article" @default.
• W2896442353 hasAuthorship W2896442353A5019350602 @default.
• W2896442353 hasAuthorship W2896442353A5057422785 @default.
• W2896442353 hasAuthorship W2896442353A5068890126 @default.
• W2896442353 hasAuthorship W2896442353A5075088781 @default.
• W2896442353 hasBestOaLocation W28964423531 @default.

• next